The impact of anti-infective drug shortages on hospitals in the United States

Trends and causes

Milena M. Griffith, Alan E. Gross, Sarah H Sutton, Maureen K Bolon, John S. Esterly, Jean A. Patel, Michael J. Postelnick, Teresa R Zembower, Marc H. Scheetz*

*Corresponding author for this work

Research output: Contribution to journalReview article

33 Citations (Scopus)

Abstract

Anti-infective shortages pose significant logistical and clinical challenges to hospitals and may be considered a public health emergency. Anti-infectives often represent irreplaceable life-saving treatments. Furthermore, few new agents are available to treat increasingly prevalent multidrug-resistant pathogens. Frequent anti-infective shortages have substantially altered patient care and may lead to inferior patient outcomes. Because many of the shortages stem from problems with manufacturing and distribution, federal legislation has been introduced but not yet enacted to provide oversight for the adequate supply of critical medications. At the local level, hospitals should develop strategies to anticipate the impact and extent of shortages, to identify therapeutic alternatives, and to mitigate potential adverse outcomes. Here we describe the scope of recent anti-infective shortages in the United States and explore the reasons for inadequate drug supply.

Original languageEnglish (US)
Pages (from-to)684-691
Number of pages8
JournalClinical Infectious Diseases
Volume54
Issue number5
DOIs
StatePublished - Mar 1 2012

Fingerprint

Legislation
Pharmaceutical Preparations
Patient Care
Emergencies
Public Health
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Griffith, Milena M. ; Gross, Alan E. ; Sutton, Sarah H ; Bolon, Maureen K ; Esterly, John S. ; Patel, Jean A. ; Postelnick, Michael J. ; Zembower, Teresa R ; Scheetz, Marc H. / The impact of anti-infective drug shortages on hospitals in the United States : Trends and causes. In: Clinical Infectious Diseases. 2012 ; Vol. 54, No. 5. pp. 684-691.
@article{1e6c8ba1d5f64b168ea766c68fd1fb70,
title = "The impact of anti-infective drug shortages on hospitals in the United States: Trends and causes",
abstract = "Anti-infective shortages pose significant logistical and clinical challenges to hospitals and may be considered a public health emergency. Anti-infectives often represent irreplaceable life-saving treatments. Furthermore, few new agents are available to treat increasingly prevalent multidrug-resistant pathogens. Frequent anti-infective shortages have substantially altered patient care and may lead to inferior patient outcomes. Because many of the shortages stem from problems with manufacturing and distribution, federal legislation has been introduced but not yet enacted to provide oversight for the adequate supply of critical medications. At the local level, hospitals should develop strategies to anticipate the impact and extent of shortages, to identify therapeutic alternatives, and to mitigate potential adverse outcomes. Here we describe the scope of recent anti-infective shortages in the United States and explore the reasons for inadequate drug supply.",
author = "Griffith, {Milena M.} and Gross, {Alan E.} and Sutton, {Sarah H} and Bolon, {Maureen K} and Esterly, {John S.} and Patel, {Jean A.} and Postelnick, {Michael J.} and Zembower, {Teresa R} and Scheetz, {Marc H.}",
year = "2012",
month = "3",
day = "1",
doi = "10.1093/cid/cir954",
language = "English (US)",
volume = "54",
pages = "684--691",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",

}

The impact of anti-infective drug shortages on hospitals in the United States : Trends and causes. / Griffith, Milena M.; Gross, Alan E.; Sutton, Sarah H; Bolon, Maureen K; Esterly, John S.; Patel, Jean A.; Postelnick, Michael J.; Zembower, Teresa R; Scheetz, Marc H.

In: Clinical Infectious Diseases, Vol. 54, No. 5, 01.03.2012, p. 684-691.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The impact of anti-infective drug shortages on hospitals in the United States

T2 - Trends and causes

AU - Griffith, Milena M.

AU - Gross, Alan E.

AU - Sutton, Sarah H

AU - Bolon, Maureen K

AU - Esterly, John S.

AU - Patel, Jean A.

AU - Postelnick, Michael J.

AU - Zembower, Teresa R

AU - Scheetz, Marc H.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Anti-infective shortages pose significant logistical and clinical challenges to hospitals and may be considered a public health emergency. Anti-infectives often represent irreplaceable life-saving treatments. Furthermore, few new agents are available to treat increasingly prevalent multidrug-resistant pathogens. Frequent anti-infective shortages have substantially altered patient care and may lead to inferior patient outcomes. Because many of the shortages stem from problems with manufacturing and distribution, federal legislation has been introduced but not yet enacted to provide oversight for the adequate supply of critical medications. At the local level, hospitals should develop strategies to anticipate the impact and extent of shortages, to identify therapeutic alternatives, and to mitigate potential adverse outcomes. Here we describe the scope of recent anti-infective shortages in the United States and explore the reasons for inadequate drug supply.

AB - Anti-infective shortages pose significant logistical and clinical challenges to hospitals and may be considered a public health emergency. Anti-infectives often represent irreplaceable life-saving treatments. Furthermore, few new agents are available to treat increasingly prevalent multidrug-resistant pathogens. Frequent anti-infective shortages have substantially altered patient care and may lead to inferior patient outcomes. Because many of the shortages stem from problems with manufacturing and distribution, federal legislation has been introduced but not yet enacted to provide oversight for the adequate supply of critical medications. At the local level, hospitals should develop strategies to anticipate the impact and extent of shortages, to identify therapeutic alternatives, and to mitigate potential adverse outcomes. Here we describe the scope of recent anti-infective shortages in the United States and explore the reasons for inadequate drug supply.

UR - http://www.scopus.com/inward/record.url?scp=84856821615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856821615&partnerID=8YFLogxK

U2 - 10.1093/cid/cir954

DO - 10.1093/cid/cir954

M3 - Review article

VL - 54

SP - 684

EP - 691

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 5

ER -